Related references
Note: Only part of the references are listed.Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer
T. T. Seppala et al.
BRITISH JOURNAL OF CANCER (2015)
Association between Body Mass Index and Mortality for Colorectal Cancer Survivors: Overall and by Tumor Molecular Phenotype
Peter T. Campbell et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival
Amanda I. Phipps et al.
GASTROENTEROLOGY (2015)
Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
Chamutal Gur et al.
IMMUNITY (2015)
Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway
Miki Ito et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer
Gilles Manceau et al.
CANCER MEDICINE (2015)
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma
Kosuke Mima et al.
JAMA ONCOLOGY (2015)
Does the microbiota play a role in the pathogenesis of autoimmune diseases?
Mairi H. McLean et al.
GUT (2015)
Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives
Aung Ko Win et al.
GUT (2015)
Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect
Xingmin Wang et al.
GUT (2015)
Associations between Cigarette Smoking, Hormone Therapy, and Folate Intake with Incident Colorectal Cancer by TP53 Protein Expression Level in a Population-Based Cohort of Older Women
Lori S. Tillmans et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Challenges and Opportunities in International Molecular Cancer Prevention Research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report
Meira Epplein et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma
Tomomitsu Tahara et al.
CANCER RESEARCH (2014)
Gut Microbial Metabolism Drives Transformation of Msh2-Deficient Colon Epithelial Cells
Antoaneta Belcheva et al.
CELL (2014)
Microbes, Microbiota, and Colon Cancer
Cynthia L. Sears et al.
CELL HOST & MICROBE (2014)
Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome
L. Flanagan et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon Cancer
Stacey Shiovitz et al.
GASTROENTEROLOGY (2014)
Colonic mucosa-associated diffusely adherent afaC plus Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer
Maelle Prorok-Hamon et al.
GUT (2014)
Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype
Antony Cougnoux et al.
GUT (2014)
Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota
Giulia Piazzi et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Tumor LINE-1 Methylation Level and Microsatellite Instability in Relation to Colorectal Cancer Prognosis
Kentaro Inamura et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review
Yu Imamura et al.
MOLECULAR CANCER (2014)
The gut microbiota, bacterial metabolites and colorectal cancer
Petra Louis et al.
NATURE REVIEWS MICROBIOLOGY (2014)
Microbiota organization is a distinct feature of proximal colorectal cancers
Christine M. Dejea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Epidemiological transition of colorectal cancer in developing countries: Environmental factors, molecular pathways, and opportunities for prevention
Faraz Bishehsari et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer
Janelle C. Arthur et al.
NATURE COMMUNICATIONS (2014)
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Aleksandar D. Kostic et al.
CELL HOST & MICROBE (2013)
Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
Mara Roxana Rubinstein et al.
CELL HOST & MICROBE (2013)
Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
Dora Colussi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication
Paul Lochhead et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease
Shuji Ogino et al.
MODERN PATHOLOGY (2013)
Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy
Reiko Nishihara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Fusobacterium Is Associated with Colorectal Adenomas
Amber N. McCoy et al.
PLOS ONE (2013)
Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
Shuji Ogino et al.
CLINICAL CANCER RESEARCH (2012)
Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
Xiaoyun Liao et al.
CLINICAL CANCER RESEARCH (2012)
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Mauro Castellarin et al.
GENOME RESEARCH (2012)
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Aleksandar D. Kostic et al.
GENOME RESEARCH (2012)
Colorectal cancer: a tale of two sides or a continuum?
Mai Yamauchi et al.
GUT (2012)
Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum
Mai Yamauchi et al.
GUT (2012)
Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
Xiaoyun Liao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
DNA Methylation Predicts Recurrence From Resected Stage III Proximal Colon Cancer
Joong Bae Ahn et al.
CANCER (2011)
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field
Shuji Ogino et al.
GUT (2011)
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
Phillip G. Febbo et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2011)
Precision of Pyrosequencing Assay to Measure LINE-1 Methylation in Colon Cancer, Normal Colonic Mucosa, and Peripheral Blood Cells
Natsumi Irahara et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
Shuji Ogino et al.
GUT (2009)
LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer
Shuji Ogino et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
PIK3CA mutation in colorectal cancer:: Relationship with genetic and epigenetic alterations
Katsuhiko Nosho et al.
NEOPLASIA (2008)
Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample
Shuji Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis
Shuji Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
Sensitive Sequencing method for KRAS mutation detection by pyrosequencing
S Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
Drug therapy - Systemic therapy for colorectal cancer
JA Meyerhardt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
